Contact Us
Home Jazz Pharmaceuticals to Present at Morgan Stanley Conference

News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals to Present at Morgan Stanley Conference

April 23, 2008
PDF Version

PALO ALTO, Calif., April 23 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bruce Cozadd, the company's Executive Chairman, will provide a corporate presentation at the Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, FL on May 1, 2008 at 8:00 a.m. Eastern Time.

A live webcast of the presentation may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website until May 15, 2008.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information, please visit http://www.JazzPharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.
CONTACT: Jim Karrels, Executive Director of Jazz Pharmaceuticals, Inc., +1-650-496-2800, investorinfo@jazzpharmaceuticals.com
Web site: http://www.jazzpharmaceuticals.com